lyell.com (LYEL) - Volume dana dhuwit perusahaan

Simbol resmi perusahaan Lyell Immunopharma (LYEL)

A steady influx of new technologies through mergers is driving growth, and the GURU.Markets portal provides this chart, where the cash capital level via 0.18 represents the current metric. The financial stability of Lyell Immunopharma (LYEL) relies on the development of exhaustion-resistant T-cell platforms. A strong R&D potential is provided by leading immunologists striving to radically increase the survival rates of cancer patients.

LYEL - Cadangan dhuwit perusahaan Lyell Immunopharma Inc ing rentang 04.07.2022 - 21.11.2026

Rincian analitis perusahaan Lyell Immunopharma

Pambiji fundamental perusahaan:Lyell LYEL
Produk merek Lyell Immunopharma, Inc.

Investors are seeking fundamental supports in financial statements to distinguish speculative growth from the issuer's actual resilience. This metric measures the volume of liquid assets generated through interest income, which determines the business's financial margin of safety. An analysis of the cash position allows for an assessment of the ability of Lyell Immunopharma (LYEL) to fund costly T-cell reprogramming developments. A stable cash balance guarantees the long-term implementation of the strategy to combat solid tumors.

Pesaing Lyell Immunopharma (LYEL)

Dhuwit awis perusahaan IBRX (ImmunityBio Corp)|Gunggung dana dhuwit perusahaan IMCR|Volume dana dhuwit perusahaan JANX (Janux Therapeutics, Inc.)|Sisa dhuwit perusahaan RCUS|zymeworks.com - Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan Tango Therapeutics Corp|Iovance Biotherapeutics (IOVA) - Dana dhuwit perusahaan|Immatics N.V. - Sisa dhuwit perusahaan|XNCR (xencor.com) - Volume dana dhuwit perusahaan|Volume dana dhuwit perusahaan Compass Therapeutics Inc|Dana dhuwit perusahaan Replimune (REPL)|IPHA: Total volume dana dhuwit perusahaan|Pyxis Oncology - Dhuwit awis perusahaan|Compugen Limited (CGEN) - Cadangan dhuwit perusahaan|IO Biotech Inc - Volume dana dhuwit perusahaan|Aset likuid perusahaan Sutro Bio STRO|INKT: Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan Werewolf (HOWL)|Dana dhuwit perusahaan immixbio.com|Dhuwit awis lan setara dhuwit awis perusahaan ALXO (ALX Oncology)|Volume dana dhuwit perusahaan CUE|PDSB (PDS Biotechnology Corporation) - Sisa dhuwit perusahaan|Volume dana dhuwit perusahaan SONN (Sonnet BioTherapeutics Holdings)|Sisa dhuwit perusahaan MAIA|Liminatus - Volume dana dhuwit perusahaan|lavatherapeutics.com - Gunggung dana dhuwit perusahaan|NextCure (NXTC) - Dana dhuwit perusahaan|Leap Therapeutics Inc - Sisa dhuwit perusahaan|Dhuwit awis perusahaan INTS|Dana dhuwit perusahaan SNSE|Volume dana dhuwit perusahaan TOVX|GRTS - Cadangan dhuwit perusahaan|Dana dhuwit perusahaan kinetabio.com KA|Sisa dhuwit perusahaan NEXI|turnstonebio.com - Volume dana dhuwit perusahaan|VCNX (Vaccinex, Inc) - Dhuwit awis lan setara dhuwit awis perusahaan|Harpoon Therapeutics (HARP) - Dana dhuwit perusahaan